The compounds have exploded in popularity, but big questions about safety and effectiveness are still unresolved.

When it comes to solving the problem of widespread EV adoption, recharge rates are one of the most commonly cited barriers, with long waits between plugs compared to refilling a tank of liquid fossil ...

First in Asean: Check if your phone can hook up direct to satellites for calls, text, data No extra hardware or modifications required: certain iPhone and Android models can connect directly to the ...

Professor Justin Roberts is employed by Anglia Ruskin University and Danone Research & Innovation, and has previously received external research funding unrelated to this article. While creatine has ...

As a dietitian in midlife, I’ve witnessed countless supplements rise and fall in the ever-changing wellness world. Trends come and go, each one claiming to be the next big thing. For years, I lumped ...

Reports that Reliance Industries has paused plans to manufacture lithium-ion battery cells have reignited debate over India's clean-energy ambitions, highlighting technology bottlenecks even as the ...

Our expert staff answers frequently asked questions in their areas of expertise and defines common terms so you can be a smarter shopper. Read more here. Creatine, once a supplement reserved for ...

This year, I took some creatine and lifted some weights, just like nearly everyone else. Until a friend casually mentioned trying creatine this past spring, I hadn’t thought much about it — it was ...

More people are turning to creatine as part of their fitness goals. Medical experts explain the benefits, risks and who should not use it. As more people set fitness goals for 2026, interest in ...

Creatine monohydrate is the most studied and offers the highest creatine per serving. Creatine HCl is more soluble, needs smaller doses, and may cause fewer digestive issues. Both boost muscle growth ...

Johnson & Johnson is paying $3.05 billion to acquire Halda Therapeutics, obtaining a novel cell death platform while strengthening its prostate cancer franchise built on Erleada. At the center of the ...

Third Arc Bio is paying $5 million upfront to use Adagene’s tech in hopes of creating two new masked T-cell engagers. Down the line, Adagene could make up to $840 million in development and commercial ...